CellMax Life Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$9M
Industry:Biotech
Founded:2013
Lead Investor(s):Artiman Ventures, several Taiwanese venture
Press

Estimated Revenue & Financials

  • CellMax Life's estimated revenue is currently $5.7M per year.
  • CellMax Life received $9.0M in venture funding in July 2016.
  • CellMax Life's estimated revenue per employee is $143375
  • CellMax Life's total funding is $9M.

Employee Data

  • CellMax Life has 40 Employees.
  • CellMax Life grew their employee count by 11% last year.
  • CellMax Life currently has 1 job openings.

Executive Contacts

NameTitle
Ben HsiehCo-Founder R&D Director
Rui MeiChief Scientific Officer
Atul SharanPresident & CEO
Twinkal MarfatiaDirector Product Management
Shih-En ChangDirector, Oncology Solutions and Clinical Affairs
Mana Kvezereli JaveyMedical Director, Vice President
Todd WhitsonChief Commercial Officer
Padma SundarVP Marketing & Business Development

What Is CellMax Life?

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax's unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

40

Number of Employees

$5.7M

Revenue (est)

1

Current Jobs

11%

Employee Growth %

$9M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.2M4310%N/A
Mission Bio
$10.7M7445%N/A
Rigel Pharmaceu...
$42M2904%N/A
ProTrials Resea...
$26.4M1823%N/A
Trace Genomics
$5.9M4137%N/A
Advanced Cell D...
$25.7M1788%N/A
CellMax Life
$5.7M4011%N/A
Vaxart
$4.2M33-15%N/A
Full Spectrum A...
$6M425%N/A
Calysta
$7.1M49-2%N/A

CellMax Life News

09/03/2019 - CellMax Life blood test study detects precancer colorectal ...

A study by CellMax Life found that the company's blood-based test was able to detect the small, precancerous colon polyps known as ...

09/08/2019 - Anatomic Pathology Market Value Trend 2019 Estimated Size ...

... CellMax Life, Digipath, Biocare Medical, AdnaGen, Angsana Molecular & Diagnostics Laboratory, Enzo Biochem, Cancer Genetics, Biocartis, ...

09/03/2019 - Anatomic Pathology Market 2019 Size, Share, Future ...

... CellMax Life, Digipath, Biocare Medical, AdnaGen, Angsana Molecular & Diagnostics Laboratory, Enzo Biochem, Cancer Genetics, Biocartis, ...

CellMax Life Funding

DateAmountRoundLead InvestorsReference
2016-07-27$9.0MA-1Artiman VenturesArticle